It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 National Heart and Lung Institute, Imperial College London, London, United Kingdom
2 Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany
3 Cologne Center for Genomics, University of Cologne, Cologne, Germany
4 Discipline of Anatomy and Histology, Bosch Institute, University of Sydney, Sydney, NSW, Australia
5 Division of Cardiovascular Medicine, Department of Physiology, University of Kentucky, Lexington, Kentucky, USA
6 Department of Cardiac Surgery, Kerckhoff-Clinic, Bad Nauheim, Germany
7 National Heart and Lung Institute, Imperial College London, London, United Kingdom; ICMC (Integrated Cardio Metabolic Centre), Myocardial Genetics, Karolinska Institutet, University Hospital, Heart and Vascular Theme, Huddinge, Sweden; AstraZeneca R&D Gothenburg, R&D, Innovative Medicines & Early Development, Cardiovascular, Renal and Metabolic Diseases (CVRM), Mölndal, Sweden